首页> 外文期刊>Journal of experimental therapeutics & oncology >Inhibition of invasion and experimental metastasis of murine melanoma cells by Ipomoea obscura (L.) is mediated through the down-regulation of inflammatory mediators and matrix-metalloproteinases.
【24h】

Inhibition of invasion and experimental metastasis of murine melanoma cells by Ipomoea obscura (L.) is mediated through the down-regulation of inflammatory mediators and matrix-metalloproteinases.

机译:通过炎症介质和基质金属蛋白酶的下调介导用IPOMOea obscura(L.)介导鼠黑色素瘤细胞侵袭和实验转移的抑制。

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, we tested the anti-metastatic activity of Ipomoea obscura extract and elucidated its underlying mechanisms by in vitro system using B16F-10 melanoma cells and in vivo experimental lung metastasis model. I. obscura suppressed proliferation, invasion and migration of highly metastatic B16F-10 melanoma cells in vitro. I. obscura could also decrease transcription factors such as nuclear factor kappaB (NF-kappaB) and activator protein (AP-1) in B16F-10 melanoma cells. Administration of I. obscura resulted significant suppression of B16F-10 melanoma induced tumor nodule formation and enhanced the survival of tumor-bearing mice. The level of various biochemical parameters associated with lung metastasis were also found to be decreased by the I. obscura treatment. A significant down regulation in the expression of inflammatory mediators such inducible nitric oxide synthase (iNOS), cyclooxygenase (COX-2), pro-inflammatory cytokines related to tumor metastasis was observed by the treatment with I. obscura. Higher expression levels of pro-metastatic genes such as matrix metalloproteinase (MMP-2 and 9), was observed in the metastatic group, but these were down-regulated by the treatment with I. obscura. The endogenous MMP inhibitor tissue inhibitor of metalloproteinases (TIMP) was found to be up-regulated by I. obscura treatment. Our results indicate that the anti- invasive and antimetastatic effect of I. obscura is mediated at least in part by reduced expression of inflammatory mediators by inhibiting NF-kappaB signaling with their downstream targets iNOS, COX-2 and pro-inflammatory cytokine and also by inhibiting MMP-9 and MMP-2.
机译:在这项研究中,我们测试了Ipomoea obscura提取物的抗转移活性,并通过使用B16F-10黑素瘤细胞和体内实验肺转移模型进行体外系统阐明其潜在机制。 I. Imbura在体外抑制高转移性B16F-10黑素瘤细胞的增殖,侵袭和迁移。 I. Imbura还可以减少B16F-10黑色素瘤细胞中核因子κB(NF-κB)和活化剂蛋白(AP-1)等转录因子。 I. Impura的施用导致B16F-10黑色素瘤诱导的肿瘤结节形成并增强肿瘤小鼠的存活率。也发现与肺转移相关的各种生化参数的水平被I. Imotha治疗减少。用I. obscura治疗观察到与肿瘤转移相关的炎症介质表达的显着下调调节炎症介质的这种诱导型一氧化氮合酶(InOS),环氧氢止酶(COX-2),促炎细胞因子。在转移基团中观察到诸如基质金属蛋白酶(MMP-2和9)的促蛋白酶蛋白酶(MMP-2和9)的更高表达水平,但通过用I. Imbura治疗下降。发现内源性MMP抑制剂组织抑制作用金属蛋白酶(TIMP)被I. Imolula治疗上调。我们的结果表明,通过抑制与其下游靶INOS,COX-2和促炎细胞因子的NF-Kappab信号传导,通过抑制NF-Kappab信号传导,I. obcura的抗侵袭性和抗常用作用至少部分地通过减少炎症介质的表达来介导。抑制MMP-9和MMP-2。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号